While the Drug Delivery to the Lungs (DDL) Conference has been a cornerstone in the inhalable drug delivery space for 36 years now, Kindeva has been pioneering solutions in this sector for over 70 years, including leading the industry’s first transition to more sustainable propellants with the world’s first CFC-free pMDI.
We’ll be attending DDL 2026 to connect with partners across the respiratory and nasal delivery ecosystem. With deep expertise in pMDIs, nasal sprays, next-generation propellants and integrated drug-device development, we’re ready to support your programs from early development to global commercial supply.
Meet our team in Edinburgh throughout the event to explore how our scientific depth, manufacturing scale and regulatory expertise can help advance your inhaled therapies and support the transition to more sustainable, patient-centric solutions.
Schedule a meeting
Schedule a meeting
Fields marked with * are required.
National Healthcare Coalition Preparedness Conference
National Harbor, ML
December 1 – 3, 2026
PDA: Universe of prefilled syringes & injection devices (UPFS) 2026
Palm Springs, California
October 6 – 7, 2026
PODD (Partnership Opportunities in Drug Delivery) 2026
Boston, Massachusetts
October 29 – 30, 2026
World Vaccine Congress Europe 2026
Amsterdam, Netherlands
October 20 – 21, 2026
Let’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.